Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio Growth (1y) (2010 - 2025)
Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -76.51% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.06% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -303.06% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 75.42% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 67.94% |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -26.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.27% |
| Sep 30, 2025 | 141.50% |
| Jun 30, 2025 | 187.63% |
| Mar 31, 2025 | 91.69% |
| Dec 31, 2024 | 292.93% |
| Sep 30, 2024 | 56.28% |
| Jun 30, 2024 | -487.40% |
| Dec 31, 2020 | 18.31% |
| Sep 30, 2020 | 610.55% |
| Jun 30, 2020 | 184.50% |
| Mar 31, 2020 | 173.66% |
| Dec 31, 2019 | 467.98% |
| Sep 30, 2019 | -37.96% |
| Jun 30, 2019 | 91.08% |
| Mar 31, 2019 | 143.89% |
| Dec 31, 2012 | -213.40% |
| Sep 30, 2012 | -100.77% |
| Mar 31, 2012 | 267.57% |
| Dec 31, 2011 | 183.09% |
| Sep 30, 2011 | 160.49% |